CP-214 Adherence to tyrosine kinase inhibitor treatments in chronic myeloid leukaemia: A pilot study

A Andújar-Mateos, AM Sánchez García, A Martínez Valero, R Antón Torres, FJ Rodríguez-Lucena, A Navarro Ruiz
  • European Journal of Hospital Pharmacy, February 2016, BMJ
  • DOI: 10.1136/ejhpharm-2016-000875.214

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1136/ejhpharm-2016-000875.214

The following have contributed to this page: Francisco Rodriguez-Lucena